|
|
|
| Let Us Handle Your Buffer Preparation | Thermo Fisher Scientific is here to support you with the buffer preparation in your manufacturing workflow. Leaving the non-core activities to us enables you to focus on the patient therapy development. Our capabilities cover off-the-shelf products like WFI, NaOH, NaCl, or EtOH, a library of the most frequently used buffers that are made-to-order, as well as fully customized buffers. |
|
|
FOCUS ON QUALITY/ANALYTICAL METHODS |
|
|
|
A conversation with Caraugh Albany, Charlie Wakeham, and Steven Erb | Three experts share their thoughts on the advances and obstacles in analytical development that they're thinking about as we head into 2025. |
|
|
|
| Flow Cytometry Panel Design Fundamentals | Poster | BD Biosciences | Multicolor flow cytometry is a powerful technology that enables simultaneous analysis of multiple markers at the single-cell level. Read on to explore the flow cytometry panel design journey. |
|
|
| Optimizing Safety Measures For rAAV Therapies | White Paper | MilliporeSigma | Learn about common process-related impurities found in recombinant Adeno-Associated Virus (rAAV) vectors and the analytical testing methods used for these residuals. |
|
|
|
|
| Comparing Real-Time And Digital PCR Technologies | Infographic | Thermo Fisher Scientific | Which PCR technologies are the most effective? Compare digital PCR (dPCR) and real-time or quantitative PCR (qPCR) to determine the best choice for your labs. |
|
|
|
|
QUALITY/ANALYTICAL METHODS SOLUTIONS |
|
|
|
|
|
| 2025 BioPlan's 22nd Annual Survey--Biopharmaceutical Manufacturing | For over 20 years, we continue to be the leader in providing the biopharma industry's most comprehensive benchmarking analysis. We invite you to participate in our 22nd Annual Survey in Biopharmaceutical Manufacturing! For all completed, qualified responses, we'll send an Amazon egift card, a copy of the summary results (mid-2025), and our 2025 Top Trends in Biomanufacturing White Paper. |
|
|
|
|
By Tyler Menichiello, editor, Bioprocess Online | In this executive roundtable discussion, Bioprocess Online editor Tyler Menichiello is joined by CEO, co-founder, and president of Ossium Health, Kevin Caldwell, CSO of FibroBiologics, Hamid Khoja, Ph.D., and president and acting CEO of Triumvira Immunologics, Rob Williamson. The panelists share their predictions and thoughts on the industry’s direction heading into 2025. They cover manufacturing trends (noting opportunities for improvements in cell therapy manufacturing), AI adoption, regulatory concerns, and the potentially difficult funding environment ahead. |
|
|
| Electronic Batch Reporting | Case Study | HighByte | Learn how a CDMO automatically created a comprehensive batch report model to drive their reporting and speed root cause identification of quality failures with an Industrial DataOps software solution. |
|
|
| Annex 1 Compliance Guidelines For Biological Indicator Users | Article | By Crystal Hostler, Mesa Laboratories | Gain a deeper understanding of the requirements, guidelines, and best practices for Annex 1 compliance whether you're in pharmaceuticals, healthcare, or any field utilizing biological indicators. |
|
|
|
|
Connect With Bioprocess Online: |
|
|
|